Jason CS YAM

  1. Home
  2. About Us
  3. Our Teams
  4. Academic & Clinical Team
  5. Jason CS YAM

Dr Jason CS YAM

Associate Professor

MB BS (HK), MPH (HK), FRCSEd, FCOphth HK, FHKAM (Ophthalmology)

Contact :

(852) 3943 5815

yamcheuksing@cuhk.edu.hk

Request An Appointment :

(852) 3943 5886

eyecentre@cuhk.edu.hk

Academic Appointments

  • Associate Professor, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
  • Head, Undergraduate Division, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
  • Head, Paediatric Ophthalmology and Strabismus Service, Hong Kong Eye Hospital
  • Honorary Associate Consultant in Hong Kong Eye Hospital
  • Head, Ophthalmology Service, Hong Kong Children’s Hospital
  • Honorary Associate Consultant in hospitals under the New Territories East Cluster
  • Director, CUHK Jockey Club Myopia Prevention Programme
  • Secretary, Hong Kong Ophthalmological Society (HKOS)
  • Council Member, College of Ophthalmologist of Hong Kong (COHK)
  • Secretary-General, Asia-Pacific Strabismus and Pediatric Ophthalmology Society (APSPOS)
  • Council Member, Asia-Pacific Myopia Society (APMS)
  • Society Representative (APSPOS), International Council of Ophthalmology (ICO)
  • Society Relations & Leadership Development Committee, International Council of Ophthalmology (ICO)
  • Secretary of Public Education Standing Committee, Asia Pacific Academy of Ophthalmology (APAO)
  • Council Member (Hong Kong) & Training and Education Committee Chair, International Pediatric Ophthalmology and Strabismus Council (IPOSC)
  • International Programme Committee, American Association for Paediatric Ophthalmology and Strabismus (AAPOS)
  • Council Member, Ophthalmology Group, Chinese Pediatric Society

Biography

Dr. Jason CS YAM is Associate Professor & Undergraduate Division Head at Department of Ophthalmology and Visual Sciences of CUHK, Head of Pediatric Ophthalmology and Strabismus service at Hong Kong Eye Hospital, and Head of Ophthalmology Service at Hong Kong Children’s Hospital. He is also Director of CUHK Jockey Club Myopia Prevention Programme. Dr. Jason CS YAM graduated as Bachelor of Medicine and Bachelor of Surgery from the University of Hong Kong in 2005. He received overseas training on Pediatric Ophthalmology and Strabismus in Great Ormond Street Hospital (2011); with Dr. David GUYTON of Johns Hopkins Hospital (2011); and with Dr. Kenneth WRIGHT in Los Angeles (2012); ocular genetics with Dr. Janey WIGGS of Harvard Medical School (2016); with Dr. Alex LEVIN of Wills Eye Hospital (2017); and Baylor College of Medicine at Texas Children Hospital (2017); ocular oncology and retinoblastoma with Dr. Jerry SHIELDS and Dr. Carol SHIELDS of Wills Eye Hospital (2017).

He serves as the Secretary-General of Asia-Pacific Strabismus and Paediatric Ophthalmology Society (APSPOS), Training and Education Committee Chair of International Paediatric Ophthalmology and Strabismus Council (IPOSC), Council Member of Asia-Pacific Myopia Society (APMS), Society Relations & Leadership Development Committee of International Council of Ophthalmology (ICO), Public Education Standing Committee Secretary, and Ophthalmic Education Standing Committee of Asia Pacific Academy of Ophthalmology (APAO), International Programme Committee of American Association for Paediatric Ophthalmology and Strabismus (AAPOS), and many other international academic positions. Nationally, he serves as the Council Member of Ophthalmology Group of Chinese Paediatric Society. Locally, he serves as Vice President of Hong Kong Ophthalmological Society (HKOS), and Council Member of College of Ophthalmologists of Hong Kong (COHK). He served as the Congress President of the Inaugural Asia-Pacific Strabismus and Paediatric Ophthalmology Society Congress 2017.

He had more than 90 publications and authored 6 book chapters; and co-authored 1 book; He is the principal investigator of research grants and external funding of 100 million HKD. He is PI of Low-concentration Atropine for Myopia Progression (LAMP) study, the first placebo-controlled RCT of 438 subjects to provide evidence for 0.05% atropine on myopia control, which confers clinical impact to millions of children worldwide. He is also PI of Hong Kong Children Eye Study, an epidemiological cohort of 30,000 children and their parents for detailed phenotypic and genotypic characterization. He has chaired 20 symposia, and has delivered 1 award lecture, 8 keynote lectures, 70 invited lectures, 50 conference papers. He also serves as an editor in 8 international journals including Scientific Reports, Medicine, BMC Ophthalmology, and Asia Pacific Journal of Ophthalmology etc.

In 2019, he received the prestigious Asia Pacific Academy of Ophthalmology Nakajima Award for being the most outstanding young ophthalmologist under aged 40 in Asia-Pacific. To recognize his global contributions on children eye care, he was named One of the Ten Outstanding Young Persons in Hong Kong in 2019, and was bestowed Hong Kong Humanity Award 2021. His other awards include Distinguished Young Fellow in Hong Kong Academy of Medicine (2013), Asia Pacific Academy of Ophthalmology Leadership Development Program Award (2015), Asia Pacific Academy of Ophthalmology Distinguished Service Award (2016), Asia Pacific Academy of Ophthalmology Achievement Award (2016), and Hospital Authority Corporate Scholarship (2016), inaugural Asia-Pacific Strabismus and Paediatric Ophthalmology Society Young Investigator Award (2017), Asia Pacific Academy of Ophthalmology Outstanding Service in Prevention of Blindness (2019), Gold Medal for Best Original Research by Young Fellows in Hong Kong Academy of Medicine (2019), and Hospital Authority Kowloon Central Cluster Outstanding Team Award (as team leader) (2020), Asia Pacific Academy of Ophthalmology Senior Achievement Award (2021), Hong Kong Youth Dream-maker Award 2021, and Hong Kong Volunteer Award 2021 (Group Award as team leader).

Research Areas

  1. Children Eye Studies: territory-based epidemiology, etiology, prevention, intervention, and molecular genetics of children eye diseases.
  2. Myopia: epidemiology, risk factors, genomic investigations, gene mapping and interventions in prevention of progression.
  3. Retinoblastoma: etiology and novel treatment modes.
  4. Intermittent exotropia: the clinical course, new methods in evaluation of the control, effective surgical approaches, surgical advancements, and prognostic factors of the surgical outcomes
  5. Genetic eye diseases: phenotypic characterization, family linkage, genomic investigations, and gene mapping of early onset glaucoma, congenital glaucoma, congenital cataracts, inherited retinal diseases, inherited corneal diseases and dysfunctions.
  6. Retinopathy of prematurity: prevention, and treatment.

Academic Activities

Paediatric Ophthalmology & Strabismus Subspecialty Liaison World Ophthalmology Congress 2018 (Spain)
Paediatric Ophthalmology & Strabismus Host Coordinator Asia-Pacific Academy Ophthalmology Congress 2018 (Hong Kong)
Congress President Asia-Pacific Strabismus and Paediatric Ophthalmology Society Congress 2017 (Hong Kong)
Pediatric Ophthalmology & Strabismus Programme Secretary Asia-Pacific Academy Ophthalmology 2017 Congress, (Singapore)
Pediatric Ophthalmology and Strabismus Programme Subspecialty Liaison World Ophthalmology Congress 2016 (Mexico)
Pediatric Ophthalmology & Strabismus Programme Secretary Asia-Pacific Academy Ophthalmology Congress 2016 (Taipei)

Research Highlights

Research Programmes

  1. Children Eye Studies: territory-based epidemiology, etiology, prevention, intervention, and molecular genetics of children eye diseases.
  2. Myopia: epidemiology, risk factors, genomic investigations, gene mapping and interventions in prevention of progression.
  3. Retinoblastoma: etiology and novel treatment modes.
  4. Intermittent exotropia: the clinical course, new methods in evaluation of the control, effective surgical approaches, surgical advancements, and prognostic factors of the surgical outcomes
  5. Genetic eye diseases: phenotypic characterization, family linkage, genomic investigations, and gene mapping of early onset glaucoma, congenital glaucoma, congenital cataracts, inherited retinal diseases, inherited corneal diseases and dysfunctions.
  6. Retinopathy of prematurity: prevention, and treatment.

Results of Note

  1. Our team has received over 100 million HKD in research funding, from University Grant Committee of Hong Kong, Hong Kong Food and Health Bureau, National Natural Science Foundation of China, Hong Kong Jockey Club Charities Trust, United Bank of Switzerland Optimus Foundation, and Children’s Cancer Foundation.
  2. Our team has conducted the Low-Concentration Atropine for Myopia Progression (LAMP) trial, which was the first placebo-controlled RCT of 438 subjects to provide evidence for 0.05% atropine on myopia control, and has changed the treatment paradigm of myopia progression worldwide. This confers clinical impact to millions of children.
  3. Our team is conducting the Hong Kong Children Eye Study, an epidemiological cohort of 30,000 children and their parents for detailed phenotypic and genotypic characterization.
  4. We are the only tertiary centre in Hong Kong to manage all retinoblastoma cases. We have launched the city-wide “Hong Kong Retinoblastoma Awareness and Education Campaign” to promote early detection of retinoblastoma in Hong Kong.
  5. The PI has been awarded the prestigious Hospital Authority Corporate Scholarship on “Paediatric Ocular Genetics”, and was commissioned to launch this service in Hong Kong.

Representative Publications:

  1. Wong ES, Choy RW, Zhang YZ, Chu WK, Chen LJ, Pang CP, Yam JC#. Global Retinoblastoma Survival and Globe Preservation – A Systematic Review and Meta- Analysis of Associations with Socioeconomic and Healthcare Factors. Lancet Global Health. 2022 Jan 27:S2214-109X(21)00555-6. doi: 10.1016/S2214-109X(21)00555-6.  
  2. Yam JC#, Jiang Y, Tang SM, Law AK, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Low-concentration Atropine for Myopia Progression Study (LAMP): One-year result of a Randomized, Double-Blinded, Placebo-Controlled Trial on Atropine 0.05%, 0.025%, and 0.01%. Ophthalmology. 2019 Jan;126(1):113-124. doi: 10.1016/j.ophtha.2018.05.029.  
  3. Yam JC#, Li FF, Zhang X, Tang SM, Yip BH, Kam KW, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Two-Year Clinical Trial of the Low-concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology. 2019 Dec 21. pii: S0161-6420(19)32356-5. doi: 10.1016/j.ophtha.2019.12.011. 
  4. Yam JC#, Zhang XJ, Zhang YZ, Wang YM, Tang SM, Li FF, Kam KW, Ko ST, Yip BHK, Young AL, Tham CC, Chen LJ, Pang CP. Three-Year Clinical Trial of Low-concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. Phase 3 Report. Ophthalmology. 2021 Oct 7:S0161-6420(21)00745-4. doi: 10.1016/j.ophtha.2021.10.002.  
  5. Li FF, Zhang YZ, Zhang XJ, Yip BHK, Tang SM, Kam KW, Young AL, Chen LJ, Tham CC, Pang CP, Yam JC#.  Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology. 2021 Jan 7:S0161-6420(21)00001-4. doi: 10.1016/j.ophtha.2020.12.036 
  6. Li FF, Kam KW, Zhang YZ, Tang SM, Young AL, Chen LJ, Tham CC, Pang CP, Yam JC#. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine in one year: Low-concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology. 2020 Dec;127(12):1603-1611. doi: 10.1016/j.ophtha.2020.06.004.  
  7. Yam JC#, Jiang Y, Lee J, Li S, Zhang YZ, Sun W, Yuan N, Wang YM, Yip HKB, Kam KW, Chan HN, Zhang XJ, Young AL, Tham CC, Cheung CY, Chu WK, Pang CP, Chen LJ. The Association of Choroidal Thickening by Atropine with Treatment Effects for Myopia: Two-Year Clinical Trial of the LAMP Study. Am J Ophthalmol. 2021 Dec 20:S0002-9394(21)00638-3. doi: 10.1016/j.ajo.2021.12.014.  
  8. Yuan N, Li J, Tang S, Li FF, Lee CO, Ng MPH, Cheung CY, Tham CC, Pang CP, Chen LJ, Yam JC#. Association of Secondhand Smoking Exposure With Choroidal Thinning in Children Aged 6 to 8 Years: The Hong Kong Children Eye Study. JAMA Ophthalmol. 2019 Oct 17:1-9. doi: 10.1001/jamaophthalmol.2019.4178. 
  9. Wong ES, Zhang XJ, Yuan N, Li J, Pang CP, Chen LJ, Tham CC, Cheung CY, Yam JC#. New OCT angiography metrics detects impaired macular microvasculature and correlates with decreased vision in amblyopic eyes: The Hong Kong Children Eye Study. JAMA Ophthalmol. 2020 Aug 1;138(8):858-865. doi: 10.1001/jamaophthalmol.2020.2220. 
  10. Tang SM, Kam KW, Chen LJ, French AN, Young AL, Rose KA, Tham CC, Pang CP, Yam JC#. Independent Influence of Parental Myopia on Childhood Myopia in a Dose-related Manner in 2055 Trios: The Hong Kong Children Eye Study. Am J Ophthalmol. 2020 Oct;218:199-207. doi: 10.1016/j.ajo.2020.05.026.  
  11. Li J, Yuan N, Chu WK, Cheung CY, Tang SM, Li FF, Chen LJ, Kam KW, Young AL, Ip P, Tham CC, Pang CP, Yam JC#. Exposure to Secondhand Smoke in School-age Children is Associated with a Thinner Retinal Nerve Fiber Layer: The Hong Kong Children Eye Study. Am J Ophthalmol. 2020 Oct 28:S0002-9394(20)30584-5. 
  12. Zhang X, Cheung SSL, Chan HN, Zhang Y, Wang YM, Yip BH, Kam KW, Yu M, Cheng CY, Young AL, Kwan MYW, Ip P, Chong KK, Tham CC, Chen LJ, Pang CP, Yam JCS#. Myopia Incidence and Lifestyle Changes Among School Children During the COVID-19 Pandemic: A Population-based Prospective Study. Br J Ophthalmol. 2021 Aug 2:bjophthalmol-2021-319307. doi: 10.1136/bjophthalmol-2021-319307.  
  13. Chen LJ#, Li FF, Lu SY, Zhang XJ, Kam KW, Tang SM, Tam PO, Yip WW, Young AL, Tham CC, Pang CP, Yam JC#. Association of Polymorphisms in ZFHX1B, KCNQ5 and GJD2 with Myopia Progression and polygenic risk prediction in Children: 3-Year Follow-up of the Hong Kong Children Eye Study. Br J Ophthalmol. 2021 Apr 2:bjophthalmol-2020-318708. doi: 10.1136/bjophthalmol-2020-318708.  
  14. Cheung CY, Li J, Lam A, Tang FY, Tham CC, Pang CP, Chen LJ, Yam JC#. Quantitative Retinal Microvasculature in Children using Swept-Source Optical Coherence Tomography: The Hong Kong Children Eye Study. Br J Ophthalmol. 2018 Jun 28. pii: bjophthalmol-2018-312413. doi: 10.1136/bjophthalmol-2018-312413.  
  15. Ho A, Cheung CY, Wong J, Tang FY, Kam KW, Young AL, Chen LJ, Wong TY, Pang CP, Tham CC, Yam JC#. Independent and Synergistic Effect of Blood Pressure and Body Mass Index on Retinal Microvasculature in Children 6-8 years: The Hong Kong Children Eye Study. J Am Heart Assoc. 2021 Feb 2;10(3):e018485. doi: 10.1161/JAHA.120.018485.  
  16. Yam JC#, Tang SM, Kam KW, Chen LJ, Yu M, Law AK, Yip BH, Wang YM, Cheung CY, Ng DS, Young AL, Tham CC, Pang CP. High Prevalence of Myopia in Children and Their Parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study. Acta Ophthalmologica. 2020 Jan 24. doi: 10.1111/aos.14350.  
  17. Tang SM, Lau T, Rong SS, Yazar S, Chen LJ, Mackey DA, Pang CP, Yam JC#. Serum vitamin D and its pathway genes in myopia: a systematic review and meta-analysis. Br J Ophthalmol. 2019 Jan;103(1):8-17. doi: 10.1136/bjophthalmol-2018-312159.  
  18. Yim CL, Tam M, Chan HL, Tang SM, Au SC, Yip WW, Ko ST, Rong SS, Chen LJ, Ng DS, Yam JC#. Antenatal steroid reduces risk of retinopathy of prematurity: A systematic review and meta-analysis. Br J Ophthalmol. 2018 Oct;102(10):1336-1341. doi: 10.1136/bjophthalmol-2017-311576.  
  19. Cheung CY, Xu D, Cheng CY, Sabanayagam C, Tham CY, Yu M, Rim TH, Chai CY, Gopinath B, Mitchell P, Poulton R, Moffitt TE, Caspi A, Yam JC, Tham CC, Jonas JB, Wang YX, Song SJ, Burrell LM, Farouque O, Li LJ, Tan G, Ting DSW, Hsu W, Lee ML, Wong TY. A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel caliber. Nat Biomed Eng. 2021 Jun;5(6):498-508. doi: 10.1038/s41551-020-00626-4.  
  20. Fabian ID, Abdallah E, Abdullahi SU…., Yam JC, Yang H, Yanga JM…Bowman R. Global Retinoblastoma Study Group. Global Retinoblastoma Presentation: Analysis by National Income Level. JAMA Oncology. 2020 May 1;6(5):685-695. doi: 10.1001/jamaoncol.2019.6716. 

(# corresponding author) 

Find out more on

In the Media

31/08/2021 Associated Press: TT HONG KONG MYOPIA
25/01/2021 港台：成人斜視治療
26/10/2020 港台 31頻道 ：護「瞳」
25/09/2020 港台第5台：小朋友疫情下如何保護眼睛
08/06/2020 Wall Street Journal ：A New Approach to Dealing With Myopia in Kids
12/12/2019 綜合報導 : 港六歲兒童的近視比率冠絕其他歐亞地區或國家